Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda Cohen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 27, 2017
Disposable Versus Reusable Absorbent Underpads for Prevention of Hospital-Acquired Incontinence-Associated Dermatitis and Pressure InjuriesKathleen Francis, Sau Man Pang, Brenda Cohen, et al.
Cancer Research|January 5, 2011
Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancerMamiko Shimizu, Brenda Cohen, Pavel Goldvasser, et al.
The American Journal of Pathology|April 26, 2007
Inhibition of notch signaling induces neural differentiation in Ewing sarcomaFrank Baliko, Tamara Bright, Raymond Poon, et al.
Breast Cancer Research and Treatment|November 17, 2009
Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancerBrenda Cohen, Mamiko Shimizu, Julia Izrailit, et al.
Cancer Discovery|August 10, 2017
Notch Shapes the Innate Immunophenotype in Breast CancerQiang Shen, Brenda Cohen, Weiyue Zheng, et al.
The Journal of Clinical Investigation|December 15, 2015
Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cellsThamotharampillai Dileepan, Erica D Smith, Daniel Knowland, et al.
Investigational New Drugs|July 18, 2013
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumorsIvan Diaz-Padilla, Hal Hirte, Amit M Oza, et al.
Cell Reports|April 11, 2019
Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate DependenciesBarbara Mair, Jelena Tomic, Sanna N Masud, et al.
Investigational New Drugs|May 7, 2013
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)Suzanne Richter, Philippe L Bedard, Eric Xueyu Chen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 27, 2017
Disposable Versus Reusable Absorbent Underpads for Prevention of Hospital-Acquired Incontinence-Associated Dermatitis and Pressure InjuriesKathleen Francis, Sau Man Pang, Brenda Cohen, et al.
Cancer Research|January 5, 2011
Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancerMamiko Shimizu, Brenda Cohen, Pavel Goldvasser, et al.
The American Journal of Pathology|April 26, 2007
Inhibition of notch signaling induces neural differentiation in Ewing sarcomaFrank Baliko, Tamara Bright, Raymond Poon, et al.
Breast Cancer Research and Treatment|November 17, 2009
Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancerBrenda Cohen, Mamiko Shimizu, Julia Izrailit, et al.
Cancer Discovery|August 10, 2017
Notch Shapes the Innate Immunophenotype in Breast CancerQiang Shen, Brenda Cohen, Weiyue Zheng, et al.
The Journal of Clinical Investigation|December 15, 2015
Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cellsThamotharampillai Dileepan, Erica D Smith, Daniel Knowland, et al.
Investigational New Drugs|July 18, 2013
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumorsIvan Diaz-Padilla, Hal Hirte, Amit M Oza, et al.
Cell Reports|April 11, 2019
Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate DependenciesBarbara Mair, Jelena Tomic, Sanna N Masud, et al.
Investigational New Drugs|May 7, 2013
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)Suzanne Richter, Philippe L Bedard, Eric Xueyu Chen, et al.
Pageof 1